Diaz, Alexis John R.
HRN: 28-01-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
11/12/2025
11/18/2025
PO
1/2 Dropper
Q4H
Oral Candidiasis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes